A healthy volunteer experimental model of inflammation to investigate the relative effectiveness of two different concentrations of EDP1815 in capsules
Latest Information Update: 16 Mar 2021
At a glance
- Drugs EDP-1815 (Primary)
- Indications Inflammation
- Focus Therapeutic Use
- 16 Mar 2021 New trial record
- 09 Mar 2021 Results presented in an Evelo Biosciences Fourth Quarter and Full Year 2020 Financial Results.